- Home
- BLNK vs IMRX Comparison
BLNK vs IMRX Comparison
Compare BLNK & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLNK
- IMRX
- Stock Information
- Founded
- BLNK 2009
- IMRX 2008
- Country
- BLNK United States
- IMRX United States
- Employees
- BLNK N/A
- IMRX N/A
- Industry
- BLNK Industrial Specialties
- IMRX Biotechnology: Pharmaceutical Preparations
- Sector
- BLNK Consumer Discretionary
- IMRX Health Care
- Exchange
- BLNK Nasdaq
- IMRX Nasdaq
- Market Cap
- BLNK 77.3M
- IMRX 68.4M
- IPO Year
- BLNK N/A
- IMRX 2021
- Fundamental
- Price
- BLNK $0.93
- IMRX $2.60
- Analyst Decision
- BLNK Buy
- IMRX Strong Buy
- Analyst Count
- BLNK 8
- IMRX 4
- Target Price
- BLNK $2.61
- IMRX $13.25
- AVG Volume (30 Days)
- BLNK 2.9M
- IMRX 2.4M
- Earning Date
- BLNK 08-06-2025
- IMRX 08-05-2025
- Dividend Yield
- BLNK N/A
- IMRX N/A
- EPS Growth
- BLNK N/A
- IMRX N/A
- EPS
- BLNK N/A
- IMRX N/A
- Revenue
- BLNK $109,383,000.00
- IMRX N/A
- Revenue This Year
- BLNK N/A
- IMRX N/A
- Revenue Next Year
- BLNK $31.15
- IMRX N/A
- P/E Ratio
- BLNK N/A
- IMRX N/A
- Revenue Growth
- BLNK N/A
- IMRX N/A
- 52 Week Low
- BLNK $0.63
- IMRX $1.00
- 52 Week High
- BLNK $3.75
- IMRX $3.83
- Technical
- Relative Strength Index (RSI)
- BLNK 59.46
- IMRX 70.10
- Support Level
- BLNK $0.84
- IMRX $1.66
- Resistance Level
- BLNK $0.92
- IMRX $2.24
- Average True Range (ATR)
- BLNK 0.07
- IMRX 0.32
- MACD
- BLNK 0.01
- IMRX 0.07
- Stochastic Oscillator
- BLNK 60.25
- IMRX 89.51
About BLNK Blink Charging Co.
Blink Charging Co is an owner, operator, and provider of electric vehicle (EV) charging services. The company offers both residential and commercial EV charging equipment, enabling EV drivers to easily recharge at various location types. The company's business is the sale and distribution of electric vehicle charging equipment and its associated revenues earned from customers and/or Property Partners who use equipment connected to its network. It earns a majority of revenue from U.S.A.
About IMRX Immuneering Corporation
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.